Check-Cap (MBAI) Liabilities and Shareholders Equity (2013 - 2025)
Check-Cap (MBAI) posted Liabilities and Shareholders Equity of $3.4 million for Q4 2025, down 40.2% sequentially from $5.8 million in Q2 2025, and up 1763.65% YoY from $184940.0 in Q4 2024.
Check-Cap (MBAI) Liabilities and Shareholders Equity (2013 - 2025) Analysis & Trends
Check-Cap has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $3.4 million in Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 1763.65% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.5 million (down 62.0% YoY) and the FY2025 annual result came in at $3.4 million, up 1763.65% from the prior year.
- Liabilities and Shareholders Equity eased to $3.4 million in Q4 2025 per MBAI's latest filing, from $5.8 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $60.6 million in Q3 2021 and troughed at $184940.0 in Q4 2024.
- A 5-year average of $34.4 million and a median of $35.1 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity sank 99.26% in 2024, then soared 1763.65% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $55.7 million in 2021, then fell by 18.36% to $45.4 million in 2022, then tumbled by 44.95% to $25.0 million in 2023, then tumbled by 99.26% to $184940.0 in 2024, then jumped by 1763.65% to $3.4 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.4 million, $5.8 million, and $184940.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 3.44 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 16.94 Bn |
| 10 | Check-Cap | 8.23 Mn | 6.60 Mn | - | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.45 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Dec 31, 2024 | 184,940.00 |
| Jun 30, 2024 | 18.09 Mn |
| Dec 31, 2023 | 25.02 Mn |
| Sep 30, 2023 | 29.03 Mn |
| Jun 30, 2023 | 33.73 Mn |
| Mar 31, 2023 | 41.31 Mn |
| Dec 31, 2022 | 45.44 Mn |
| Sep 30, 2022 | 49.55 Mn |
| Jun 30, 2022 | 54.13 Mn |
| Mar 31, 2022 | 59.59 Mn |
| Dec 31, 2021 | 55.66 Mn |
| Sep 30, 2021 | 60.58 Mn |
| Jun 30, 2021 | 32.61 Mn |
| Mar 31, 2021 | 36.52 Mn |
| Dec 31, 2020 | 19.64 Mn |
| Sep 30, 2020 | 23.19 Mn |
| Jun 30, 2020 | 17.88 Mn |
| Mar 31, 2020 | 10.60 Mn |